Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China flag China · Delayed Price · Currency is CNY
64.94
+1.74 (2.75%)
Feb 4, 2026, 3:04 PM CST

SHE:300347 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
6,4326,4747,2897,0025,1873,176
Other Revenue
129.04129.0494.9383.9326.1716.04
6,5616,6037,3847,0855,2143,192
Revenue Growth (YoY)
-3.53%-10.58%4.21%35.91%63.32%13.88%
Cost of Revenue
4,8224,3594,5394,2772,9431,678
Gross Profit
1,7402,2442,8452,8082,2711,514
Selling, General & Admin
947.38944.45837.52780.02676.88487.22
Research & Development
257.53238.39261.56234.62211.83156.65
Other Operating Expenses
20.6622.219.157.1712.53.67
Operating Expenses
1,2381,2351,1551,046926.93635.57
Operating Income
501.811,0091,6901,7631,344878.67
Interest Expense
-186.02-141.24-119.9-83.18-24.91-50.78
Interest & Investment Income
587.92256.86568.02330.09568.16394.16
Currency Exchange Gain (Loss)
18.0218.022.6120.13-11.83-147.08
Other Non Operating Income (Expenses)
-14.89-6.59-3.32-6.88-1.48-2.48
EBT Excluding Unusual Items
906.841,1372,1382,0231,8741,073
Impairment of Goodwill
-5-5-29.16---
Gain (Loss) on Sale of Investments
-144.08-501.69352.77535.861,8151,138
Gain (Loss) on Sale of Assets
6.113.56-0.19-0.09-0.53-0.89
Asset Writedown
5.26---0.45--
Other Unusual Items
31.0531.0527.2427.1-3.969.2
Pretax Income
800.18664.462,4892,5853,6852,219
Income Tax Expense
163.8216.63338.61313.65292.86189.71
Earnings From Continuing Operations
636.38447.832,1502,2723,3922,029
Minority Interest in Earnings
-24.23-42.69-125.08-265.17-517.54-279.23
Net Income
612.15405.142,0252,0072,8741,750
Net Income to Common
612.15405.142,0252,0072,8741,750
Net Income Growth
-36.15%-79.99%0.91%-30.19%64.26%107.90%
Shares Outstanding (Basic)
857863865865868795
Shares Outstanding (Diluted)
857863865866871799
Shares Change (YoY)
-0.83%-0.22%-0.07%-0.62%9.01%7.27%
EPS (Basic)
0.710.472.342.323.312.20
EPS (Diluted)
0.710.472.342.323.302.19
EPS Growth
-35.55%-79.94%0.86%-29.70%50.69%93.81%
Free Cash Flow
1,006740.45836.68908.91,055842.18
Free Cash Flow Per Share
1.170.860.971.051.211.05
Dividend Per Share
0.3000.3000.5680.5500.5000.300
Dividend Growth
-47.18%-47.18%3.27%10.00%66.67%7.91%
Gross Margin
26.51%33.99%38.53%39.64%43.55%47.44%
Operating Margin
7.65%15.29%22.89%24.88%25.77%27.52%
Profit Margin
9.33%6.14%27.42%28.32%55.13%54.81%
Free Cash Flow Margin
15.33%11.21%11.33%12.83%20.24%26.38%
EBITDA
722.161,2151,8761,9211,458958.59
EBITDA Margin
11.01%18.40%25.40%27.12%27.97%30.03%
D&A For EBITDA
220.34205.22185.06158.69114.7179.92
EBIT
501.811,0091,6901,7631,344878.67
EBIT Margin
7.65%15.29%22.89%24.88%25.77%27.52%
Effective Tax Rate
20.47%32.60%13.61%12.13%7.95%8.55%
Revenue as Reported
6,5616,6037,3847,0855,2143,192
Advertising Expenses
-14.119.9719.2414.4510.98
Source: S&P Global Market Intelligence. Standard template. Financial Sources.